High Abstinence Rates in Heroin Addicts by a New Comprehensive Treatment Approach

REFERENCES

• Brink van den W, Ree van JM. Pharmacological treatments for heroin and cocaine addiction. Eur Neuropsychopharmacol. 2003;13:476–487.
   Google Scholar
• Amato L, Davoli M, Ferri M, Ali R. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev. 2003;3:CD003409.
   Google Scholar
• Krantz MJ, Mehler PS. Treating opioid dependence. Growing implications for primary care. Arch Intern Med. 2004;164:277–288.
   PubMed Web of Science ®Google Scholar
• Kasser C, Geller A, Howell E, Wartenberg A. Detoxification: Principles and Protocols. Chevy Chase, Md.: American Society of Addiction Medicine, Inc; 1997.
   Google Scholar
• Gowing L, Ali R, White J. (2002) Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev. 2002;2:CD002022.
   Google Scholar
• Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2003;3:CD001333.
   Google Scholar
• Kleber HD. Pharmacologic treatments for heroin and cocaine dependence. Am J Addict. 2003;12(Suppl. 2):S5–S18.
   PubMed Web of Science ®Google Scholar
• Roozen HG, Kerkhof AJFM, Brink van den W. Experiences with an outpatient relapse program (CRA) combined with naltrexone in the treatment of opioid dependence: effect on addictive behaviours and the predictive validity of psychiatric comorbidity. Eur Addict Res. 2003;9:53–58.
   PubMed Web of Science ®Google Scholar
• Weiss RD. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction. 2004;99:1382–1392.
   PubMed Web of Science ®Google Scholar
• Meyers RJ, Smith JE. Clinical Guide to Alcohol Treatment: The Community Reinforcement Approach. New York, NY: Guilford Press; 1995.
   Google Scholar
• Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CAJ, Kerkhof AJFM. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend. 2004;74:1–13.
   PubMed Web of Science ®Google Scholar
• De Jong CAJ, Laheij RJF, Krabbe PFM. General anaesthesia does not improve outcome in opioid antagonist detoxification: a randomized controlled trial. Addiction. 2005;100:206–215.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• Roozen HG, De Jong CAJ, Kerkhof AJFM, Geerlings PJ, Schippers GM. EDOCRA: handleiding CRA., Novadic: Sint Oedenrode; 2000.
   Google Scholar
• Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1995;1:208–210.
   Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.
   PubMed Web of Science ®Google Scholar
• Derogatis LR. SCL-90-R: Administration, Scoring and Procedures. Manual II. Towson, Md.: Clinical Psychometric Research; 1983.
   Google Scholar
• Gerra G, Zaimovic A, Rustichelli P, , et al. Rapid opiate detoxification in outpatient treatment: relationship with naltrexone compliance. J Subst Abuse Treat. 2000;18:185–191.
   PubMed Web of Science ®Google Scholar
• McGregor C, Ali R, White JM, Thomas P, Gowing L. A comparison of antagonist-precipitated withdrawal under anaesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug Alcohol Depend. 2002;68:5–14.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Ball SA, Nich C, , et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry. 2001;58:755–761.
   PubMed Web of Science ®Google Scholar
• O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998;279:229–234.
   PubMed Web of Science ®Google Scholar
• Gowing L, Ali R, White J. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev. 2002;2:CD002021.
   Google Scholar
• Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD). J Addict Dis. 2000;19:11–28.
   PubMed Web of Science ®Google Scholar
• Bochud Tornay C, Favrat B, Monnat M, , et al. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results. Drug Alcohol Depend. 2003;69:283–288.
   PubMed Web of Science ®Google Scholar
• Cucchia AT, Monnat M, Spagnoli J, Ferrero F, Bertschy G. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Drug Alcohol Depend. 1998;52:243–250.
   PubMed Web of Science ®Google Scholar
• Hensel M, Kox WJ. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand. 2000;44:326–333.
   PubMed Web of Science ®Google Scholar
• Lawental E. Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program—a retrospective follow-up study. J Subst Abuse. 2000;11:173–181.
   PubMedGoogle Scholar
• Rabinowitz J, Cohen H, Tarrasch R, Kotler M. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study. Drug Alcohol Depend. 1997;47:77–86.
   PubMed Web of Science ®Google Scholar
• Rabinowitz J, Cohen H, Kotler M. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling. Psychiatr Serv. 1998;49:831–833.
   PubMedGoogle Scholar
• Rabinowitz J, Cohen H, Atias S. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification. Am J Addict. 2002;11:52–56.
   PubMed Web of Science ®Google Scholar
• Favrat B, Zimmerman G, Zullino D, , et al. Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial. Drug Alcohol Depend. 2006;81:109–116.
   PubMed Web of Science ®Google Scholar
• Brink van den W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ. 2003;327(7410):310. Erratum in: BMJ. 2003;327(7417):724.
   Google Scholar
• Caetano R. Standards for reporting non-randomized evaluations of behavioral and public health interventions: the TREND statement. Addiction. 2004;99:1075–1080.
   Google Scholar